Serum MMP-8 and promotor MMP-8 -799 G>A SNP as possible markers of non-eosinophilic bronchial asthma

Authors:

Abstract
Bronchial asthma is a complex heterogenous chronic inflammatory lung disease that presents with several clinical phenotypes with a distinct pathobiology and biomarkers. In the current preliminary study, we aimed to evaluate the possible role of MMP-8 and MMP-8 -799 G>A (rs11225395) promoter polymorphism as biomarkers in bronchial asthma. The genotyping of patients’ and control groups was performed by PCR-RFLP method and the serum level was assessed by ELISA method. The AA genotype was with marginal significance more common among controls (0.289) than in patients (0.129) when compared to the wild type G allele genotypes (GG+GA, p=0.040). A higher serum levels of MMP-8 was found in asthma patients (5.45±0.62 (SEM) ng/ml) than to control individuals (2.71±0.52 ng/ml, p=0.010). No significant difference was seen in serum MMP-8 neither in controls or in patients with different MMP8 genotype (p=0.556 and p=0.465). Serum MMP-8 correlated negatively with blood eosinophils (Rho= -0.531, pA SNP might be protective both for development and progression of bronchial asthma. Funding: University Project 3/2023, Trakia University and Project No. BG-RRP-2.004-0006-C02.